These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1695491)

  • 1. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine.
    Gordon DM; Cosgriff TM; Schneider I; Wasserman GF; Majarian WR; Hollingdale MR; Chulay JD
    Am J Trop Med Hyg; 1990 Jun; 42(6):527-31. PubMed ID: 1695491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing of Plasmodium vivax CS proteins in Saimiri monkeys.
    Collins WE
    Bull World Health Organ; 1990; 68 Suppl(Suppl):42-6. PubMed ID: 2094590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
    Herrington DA; Losonsky GA; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman SL; Gordon DM; Levine MM; Edelman R
    Vaccine; 1992; 10(12):841-6. PubMed ID: 1455910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ballou WR; Ruebush TK; Nardin EH; Chulay JD; Majarian WR; Young JF; Wasserman GF; Bathurst I
    Am J Trop Med Hyg; 1989 May; 40(5):455-64. PubMed ID: 2658634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax.
    Collins WE; Nussenzweig RS; Ruebush TK; Bathurst IC; Nardin EH; Gibson HL; Campbell GH; Barr PJ; Broderson JR; Skinner JC
    Am J Trop Med Hyg; 1990 Dec; 43(6):576-83. PubMed ID: 1702586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
    Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium vivax: a monoclonal antibody recognizes a circumsporozoite protein precursor on the sporozoite surface.
    Gonzalez-Ceron L; Rodriguez MH; Wirtz RA; Sina BJ; Palomeque OL; Nettel JA; Tsutsumi V
    Exp Parasitol; 1998 Nov; 90(3):203-11. PubMed ID: 9806864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
    Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
    Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans.
    Franke ED; Lucas CM; Chauca G; Wirtz RA; Hinostroza S
    Am J Trop Med Hyg; 1992 Mar; 46(3):320-6. PubMed ID: 1373042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.
    Charoenvit Y; Collins WE; Jones TR; Millet P; Yuan L; Campbell GH; Beaudoin RL; Broderson JR; Hoffman SL
    Science; 1991 Feb; 251(4994):668-71. PubMed ID: 1704150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.
    Herrington DA; Nardin EH; Losonsky G; Bathurst IC; Barr PJ; Hollingdale MR; Edelman R; Levine MM
    Am J Trop Med Hyg; 1991 Dec; 45(6):695-701. PubMed ID: 1763796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium berghei subunit vaccine: repeat synthetic peptide of circumsporozoite protein comprising T- and B-cell epitopes fails to confer immunity.
    Migliorini P; Boulanger N; Betschart B; Corradin G
    Scand J Immunol; 1990 Feb; 31(2):237-42. PubMed ID: 1689867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66.
    Millet P; Campbell GH; Sulzer AJ; Grady KK; Pohl J; Aikawa M; Collins WE
    Am J Trop Med Hyg; 1993 Mar; 48(3):424-31. PubMed ID: 7682382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine.
    Ballou WR; Hoffman SL; Sherwood JA; Hollingdale MR; Neva FA; Hockmeyer WT; Gordon DM; Schneider I; Wirtz RA; Young JF
    Lancet; 1987 Jun; 1(8545):1277-81. PubMed ID: 2884410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites.
    Pessi A; Michel M; Bianchi E; Mendis A; Tougne C; Verdini AS; Lambert PH; Carter R; Mendis K; Del Giudice G
    Am J Trop Med Hyg; 1990 Jan; 42(1):17-23. PubMed ID: 1689124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell epitopes of the circumsporozoite protein of Plasmodium vivax. Recognition by lymphocytes of a sporozoite-immunized chimpanzee.
    Nardin E; Clavijo P; Mons B; van Belkum A; Ponnudurai T; Nussenzweig RS
    J Immunol; 1991 Mar; 146(5):1674-8. PubMed ID: 1704402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune responses to the circumsporozoite protein of Plasmodium vivax in Madagascar.
    Migot F; Millet P; Chougnet C; Lepers JP; Deloron P
    Am J Trop Med Hyg; 1993 Apr; 48(4):524-9. PubMed ID: 7683178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems.
    Bathurst IC; Gibson HL; Kansopon J; Hahm BK; Hollingdale MR; Barr PJ
    Biotechnol Ther; 1992; 3(1-2):15-34. PubMed ID: 1305890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.